Allscripts considers buyout offers

Blackstone, Carlyle and Silver Lake are among the bidders for this electronic health records company.

By Minyanville.com Oct 8, 2012 3:39PM
Image, Pills, by Sean Justice of CorbisAfter announcing late last month that it is contemplating selling itself, Allscripts Healthcare Solutions (MDRX) has received first-round leveraged buyout bids from private equity groups such as Blackstone Group (BX), Carlyle Group (CG), and Silver Lake Management, reports Bloomberg News. The stock is trading higher as a result. 
 
The electronic health-records provider, which has retained Citigroup (C) as its advisor on the sale, now wants second-round offers in the next three to four weeks, sources told Bloomberg.
 
Allscripts has had a troubled year. After the company fired chairman Phil Pead in April, three directors also left with Pead in protest. Allscripts then faced a proxy battle with major shareholder, hedge fund Healthcor Management, which eventually placed three of its candidates on Allscript’s board in June.
 
Leo Carpio, an analyst at Caris & Co in New York, noted on October 1 that Allscripts may have felt greater pressure to sell after it lost out on a $302 million contract to manage the record systems for New York City public hospitals.
 
In the past week, a slew of analysts covering Allscripts have revised their targets on shares of the company. ISI Group moved Allscripts to Overweight from Buy and upped its price target to $14.50 from $11.50. Analysts at Cowen moved the company to Outperform from Neutral, while those at Robert W. Baird raised their target from $15 to $17.
 
Sterne Agee, which has a Buy rating on Allscripts, also lifted its price target to $15 from $13.50, saying in a note, "Our analysis suggests a $15-$19 valuation range for MDRX shares should a go-private transaction be consummated by year-end. At the low end, this valuation range is 20% above today’s closing price, while the top end implies 50% upside. As such, we have raised our price target to $15 per share from $13.50."
 
Shares of Allscripts were down 29.62% year to date before Monday’s open.


More from Minyanville
Tags: BXCCGMDRX
0Comments

DATA PROVIDERS

Copyright © 2013 Microsoft. All rights reserved.

Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.

Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.

Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.

STOCK SCOUTER

StockScouter rates stocks from 1 to 10, with 10 being the best, using a system of advanced mathematics to determine a stock's expected risk and return. Ratings are displayed on a bell curve, meaning there will be fewer ratings of 1 and 10 and far more of 4 through 7.

131
131 rated 1
262
262 rated 2
442
442 rated 3
601
601 rated 4
718
718 rated 5
587
587 rated 6
610
610 rated 7
456
456 rated 8
279
279 rated 9
124
124 rated 10
12345678910

Top Picks

SYMBOLNAMERATING
ABTAbbott Laboratories10
AIGAmerican International Group Inc10
ATVIActivision Blizzard Inc10
CACA Inc10
CSCOCisco Systems Inc10
More
Fidelity Brokerage Services, Member NYSE, SIPC. (c) 2011 FMR LLC. All rights reserved

VIDEO ON MSN MONEY

ABOUT

Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.

Contributors include professional investors and journalists affiliated with MSN Money.

Follow us on Twitter @topstocksmsn.